Inferring sources of substandard and falsified products in pharmaceutical supply chains

References

• Ainslie, A., Drèze, X. and Zufryden, F. (2005) Modeling movie life cycles and market share. Marketing Science, 24(3), 508–517.
   Web of Science ®Google Scholar
• Anzoom, R., Nagi, R. and Vogiatzis, C. (2022) A review of research in illicit supply-chain networks and new directions to thwart them. IISE Transactions, 54(2), 134–158.
   Web of Science ®Google Scholar
• Basu, G. (2014) Concealment, corruption, and evasion: A transaction cost and case analysis of illicit supply chain activity. Journal of Transportation Security, 7(3), 209–226.
   Google Scholar
• Cao, J., Davis, D., Wiel, S.V. and Yu, B. (2000) Time-varying network tomography: Router link data. Journal of the American Statistical Association, 95(452), 1063–1075.
   Web of Science ®Google Scholar
• Castro, R., Coates, M., Liang, G., Nowak, R. and Yu, B. (2004) Network tomography: Recent developments. Statistical Science, 19(3), 499–517.
   Web of Science ®Google Scholar
• Chen, A., Cao, J. and Bu, T. (2010) Network tomography: Identifiability and Fourier domain estimation. IEEE Transactions on Signal Processing, 58(12), 6029–6039.
   Web of Science ®Google Scholar
• Chen, H.H., Higgins, C., Laing, S.K., Bliese, S.L., Lieberman, M. and Ozawa, S. (2021) Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study. Medicine Access @ Point of Care, 5, 1–11.
   Google Scholar
• Cockburn, R., Newton, P.N., Agyarko, E.K., Akunyili, D. and White, N.J. (2005) The global threat of counterfeit drugs: Why industry and governments must communicate the dangers. PLoS Medicine, 2(4), e100.
   PubMed Web of Science ®Google Scholar
• Diestel, R. (2005) Graph Theory. 3rd edition, Graduate Texts in Mathematics, Vol. 173. Springer Verlag, New York, NY.
   Google Scholar
• Eban, K. (2019) Bottle of Lies: The Inside Story of the Generic Drug Boom, Ecco, an imprint of HarperCollins Publishers, New York, NY.
   Google Scholar
• Hamilton, W.L., Doyle, C., Halliwell-Ewen, M. and Lambert, G. (2016) Public health interventions to protect against falsified medicines: A systematic review of international, national and local policies. Health Policy and Planning, 31(10), 1448–1466.
   PubMed Web of Science ®Google Scholar
• Hoffman, M.D. and Gelman, A. (2014) The no-U-turn sampler: Adaptively setting path lengths in Hamiltonian Monte Carlo. Journal of Machine Learning Research, 15(1), 1593–1623.
   Google Scholar
• Hui, S., Krishnamurthy, P., Kumar, S., Siddegowda, H.B. and Patel, P. (2020) Understanding the effectiveness of peer educator outreach on reducing sexually transmitted infections: The role of prevention vs. early detection. Marketing Science, 39(3), 500–515.
   Web of Science ®Google Scholar
• Hussain, D.M.A. and Arroyo, D.O. (2008) Locating key actors in social networks using Bayes’ posterior probability framework, in European Conference on Intelligence and Security Informatics. DOI:10.1007/978-3-540-89900-6_6
   Google Scholar
• Karunamoorthi, K. (2014) The counterfeit anti-malarial is a crime against humanity: A systematic review of the scientific evidence. Malaria Journal, 13(1), 209. DOI:10.1186/1475-2875-13-209
   PubMed Web of Science ®Google Scholar
• Koczwara, A. and Dressman, J. (2017) Poor-quality and counterfeit drugs: A systematic assessment of prevalence and risks based on data published from 2007 to 2016. Journal of Pharmaceutical Sciences, 106(10), 2921–2929.
   PubMed Web of Science ®Google Scholar
• Kovacs, S., Hawes, S.E., Maley, S.N., Mosites, E., Wong, L. and Stergachis, A. (2014) Technologies for detecting falsified and substandard drugs in low and middle-income countries. PLoS ONE, 9(3), e90601.
   PubMed Web of Science ®Google Scholar
• Mann, P.S. (2010) Introductory Statistics, 7th edition. Wiley, Hoboken, NJ.
   Google Scholar
• Newton, P.N., Green, M.D., Mildenhall, D.C., Plançon, A., Nettey, H., Nyadong, L., Hostetler, D.M., Swamidoss, I., Harris, G.A., Powell, K., Timmermans, A.E., Amin, A.A., Opuni, S.K., Barbereau, S., Faurant, C., Soong, R.C., Faure, K., Thevanayagam, J., Fernandes, P., Kaur, H., Angus, B., Stepniewska, K., Guerin, P.J. and Fernandez, F.M. (2011) Poor quality vital anti-malarials in Africa - an urgent neglected public health priority. Malaria Journal, 10, 352. DOI:10.1186/1475-2875-10-352
   PubMed Web of Science ®Google Scholar
• Newton, P.N., Lee, S.J., Goodman, C., Fernández, F.M., Yeung, S., Phanouvong, S., Kaur, H., Amin, A.A., Whitty, C.J.M., Kokwaro, G.O., Lindegárdh, N., Lukulay, P., White, L.J., Day, N.P.J., Green, M.D. and White, N.J. (2009) Guidelines for field surveys of the quality of medicines: A proposal. PLoS Medicine, 6(3), e1000052.
   PubMed Web of Science ®Google Scholar
• Ni, J., Xie, H., Tatikonda, S. and Yang, Y.R. (2010) Efficient and dynamic routing topology inference from end-to-end measurements. IEEE/ACM Transactions on Networking, 18(1), 123–135.
   Web of Science ®Google Scholar
• Nkansah, P., Smine, K., Pribluda, V., Phanouvong, S., Dunn, C., Walfish, S., Umaru, F., Clark, A., Kaddu, G., Hajjou, M., Nwokike, J. and Evans, L. (2017) Guidance for Implementing Risk-Based Post-Marketing Quality Surveillance in Low- and Middle-Income Countries. U.S. Pharmacopeial Convention. The Promoting the Quality of Medicines Program. Rockville, MD.
   Google Scholar
• Ozawa, S., Evans, D., Bessias, S., Haynie, D.G., Yemeke, T.T., Laing, S.K. and Herrington, J.E. (2018) Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: A systematic review and meta-analysis. JAMA Network Open, 1(4), e181662.
   PubMed Web of Science ®Google Scholar
• Pisani, E., Nistor, A.-L., Hasnida, A., Parmaksiz, K., Xu, J. and Kok, M.O. (2019) Identifying market risk for substandard and falsified medicines: An analytic framework based on qualitative research in China, Indonesia, Turkey and Romania. Wellcome Open Research, 4, 70. DOI:10.12688/wellcomeopenres.15236.1
   PubMedGoogle Scholar
• Rotunno, R., Cesarotti, V., Bellman, A., Introna, V. and Benedetti, M. (2014) Impact of track and trace integration on pharmaceutical production systems. International Journal of Engineering Business Management, 6. DOI:10.5772/58934
   Google Scholar
• Schwartz, D.M. and Rouselle, T. (2009) Using social network analysis to target criminal networks. Trends in Organized Crime, 12, 188–207.
   Google Scholar
• Suleman, S., Zeleke, G., Deti, H., Mekonnen, Z., Duchateau, L., Levecke, B., Vercruysse, J., D’Hondt, M., Wynendaele, E. and De Spiegeleer, B. (2014) Quality of medicines commonly used in the treatment of soil transmitted Helminths and Giardia in Ethiopia: A nationwide survey. PLoS Neglected Tropical Diseases, 8(12), e3345.
   PubMed Web of Science ®Google Scholar
• Tebaldi, C. and West, M. (1998) Bayesian inference on network traffic using link count data. Journal of the American Statistical Association, 93(442), 557–573.
   Web of Science ®Google Scholar
• Triepels, R., Daniels, H. and Feelders, A. (2018) Data-driven fraud detection in international shipping. Expert Systems with Applications, 99, 193–202.
   Web of Science ®Google Scholar
• UNICRI. (2012) Counterfeit Medicines and Organized Crime. Turin, Italy.
   Google Scholar
• USP. (July 2020) Increasing Transparency in the Medicines Supply Chain. Rockville, MD.
   Google Scholar
• USP. (2021) Medicines Quality Database. Available at %5Curl%7Bapps.usp.org/app/worldwide/medQuality%20Database/selectGeoLocation.html%7D (accessed 12 June 2021).
   Google Scholar
• Wickett, E., Plumlee, M. and Smilowitz, K. (2021) Logistigate User’s Manual. Version 0.1.1. Available at https://logistigate.readthedocs.io (accessed 1 November 2021).
   Google Scholar
• WHO. (2017a) A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• WHO. (2017b) WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• WHO. (2018) Substandard and Falsified Medical Products - Key Facts. Available at https://www.who.int/en/news-room/fact-sheets/detail/substandard-and-falsified-medical-products (accessed 20 June 2022).
   Google Scholar